News from bio-solutions corp A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( OTC-PINK:ABEC,OTC-QB:ABEC)

Aug 28, 2013, 07:30 ET

Bio-Solutions Corp. Announces National Direct Response Marketing Campaign for Type2Defense™

Bio-Solutions Corp. (OTCQB: BISU) today announces a major step in their company's expansion process across the USA and commitment to growth across...

Aug 27, 2013, 07:30 ET

Bio-Solutions Corporation Announces Campaign on Lockerdome.com to Help Raise Money for the Benefit of Juvenile Diabetes

Bio-Solutions Corporation (OTCQB: BISU) is pleased to announce that we have initiated a campaign on Lockerdome.com to help raise money for the...

Oct 09, 2012, 08:52 ET

Bio-Solutions Corp/ Type2 Defense™ Officially Retains BOSS Creative

Bio-Solutions Corp (OTCQB: BISU) (PINKSHEETS: BISU) is pleased to announce that the company has recently acquired Type2 Defense™. Type2...

Aug 14, 2012, 08:00 ET

Bio-Solutions Corp. Files Quarterly 10Q and Cleans up the Balance Sheet

 Bio-Solutions Corp, (OTCQB: BISU) (PINKSHEETS: BISU) is pleased to inform shareholders of the company's recent Quarterly filing.  This...

Aug 10, 2012, 08:00 ET

Bio-Solutions Corp. Shareholder Update

 Bio-Solutions Corp, (OTCQB: BISU) (PINKSHEETS: BISU)is pleased to provide a shareholder update on recent news, events and the state of the...

Aug 07, 2012, 08:00 ET

Highly Regarded Naturopath to Join Bio-Solutions Corp

 Bio-Solutions Corp (OTCQB: BISU) (PINKSHEETS: BISU) is pleased to announce the addition of Ms. Dana Kraft as a team member.  Ms....

Jul 30, 2012, 09:36 ET

Bio-Solutions Corp Begins Production of the Type2 Defense™. Pursuing $25 Billion plus Type II and Pre-Diabetic Marketplace

(OTCQB: BISU) (PINKSHEETS: BISU) Bio-Solutions Corp is pleased to announce that the company has started production of the recently acquired Type2...